Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jan 20:23:908-917.
doi: 10.1016/j.omtn.2021.01.010. eCollection 2021 Mar 5.

Pathogenic mechanisms and the potential clinical value of circFoxo3 in cancers

Lei Zhang  1 , Yin Wang  1 , Yuan Zhang  1 , Yanfang Zhao  2 , Peifeng Li  1
Affiliations
Review

Pathogenic mechanisms and the potential clinical value of circFoxo3 in cancers

Lei Zhang et al. Mol Ther Nucleic Acids. .

Abstract

Circular RNAs (circRNAs) are covalently closed circular structures that can function in various physiological and pathological processes by acting as microRNA (miRNA) sponges, RNA-binding protein (RBP) sponges, mRNA transcriptional regulators, and protein translational templates. circFoxo3 is one of the most studied circRNAs and is generated from the tumor suppressor gene Foxo3. Increasing studies have demonstrated the multiple functions of circFoxo3 in the pathogenesis of different cancer types. circFoxo3 plays important roles in cancer development mainly by binding to various miRNAs. The diagnostic potential of circFoxo3 has been revealed in several cancers. Some research results have been found to contradict the results of other studies, and this may be due to insufficient sample sizes and inconsistencies in the experimental and nomenclature methods. In this review, we systematically summarize current knowledge about the biogenesis and functions of circRNAs, elucidate the roles of circFoxo3 in different cancers, and explore the clinical applications of circFoxo3.

Keywords: action modes; biogenesis; cancer pathogenesis; circFoxo3; circular RNAs; clinical application.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

None
Graphical abstract
Figure 1
Figure 1
Biogenesis models and the underlying action mechanisms of circRNAs (A) Lariat-driven circularization model dependent on the splice donor and acceptor can produce exonic circRNAs (ecRNAs). (B) Intron pairing-driven circularization indicated by the pairing of RNA base motifs (e.g., Alu repeats, red arrows) in introns can generate ecRNAs or exon-intron circRNAs (EIciRNAs). (C) RNA-binding proteins (RBPs) can bridge with pre-mRNAs to produce ecRNAs or EIciRNAs. (D) Circular intronic RNA (ciRNA) is generated by a back-splicing process. (E) circRNAs can bind to miRNAs to influence their function. (F) circRNAs can associate with RBPs to regulate the subsequent pathways. (G) circRNAs can encode proteins assisted by internal ribosome entry site (IRES38100136525000000) elements or m6A modifications (blue pin-2730572390000000). (H) ciRNAs and EIciRNAs can regulate the expression of parental genes by binding to RNA polymerase II (Pol II).
Figure 2
Figure 2
circFoxo3 participates in various types of cancers through different pathways circFoxo3 can suppress the pathogenesis of non-small cell lung cancer, prostate cancer, breast cancer, esophageal squamous cell cancer, and bladder cancer. On the contrary, circFoxo3 can promote the pathogenesis of gastric carcinoma, glioblastoma, prostate cancer, and hepatocellular carcinoma. In particular, circFoxo3 was reported to have the opposite effect in two studies on prostate cancer.
See this image and copyright information in PMC

References

    1. Zhang L., Zhang Y., Zhao Y., Wang Y., Ding H., Xue S., Li P. Circulating miRNAs as biomarkers for early diagnosis of coronary artery disease. Expert Opin. Ther. Pat. 2018;28:591–601. - PubMed
    1. Zhang Y., Zhang L., Wang Y., Ding H., Xue S., Yu H., Hu L., Qi H., Wang Y., Zhu W. KCNQ1OT1, HIF1A-AS2 and APOA1-AS are promising novel biomarkers for diagnosis of coronary artery disease. Clin. Exp. Pharmacol. Physiol. 2019;46:635–642. - PubMed
    1. Zhang L., Zhang Y., Xue S., Ding H., Wang Y., Qi H., Wang Y., Zhu W., Li P. Clinical significance of circulating microRNAs as diagnostic biomarkers for coronary artery disease. J. Cell. Mol. Med. 2020;24:1146–1150. - PMC - PubMed
    1. Zhou B., Yu J.W. A novel identified circular RNA, circRNA_010567, promotes myocardial fibrosis via suppressing miR-141 by targeting TGF-β1. Biochem. Biophys. Res. Commun. 2017;487:769–775. - PubMed
    1. Li M., Ding W., Tariq M.A., Chang W., Zhang X., Xu W., Hou L., Wang Y., Wang J. A circular transcript of ncx1 gene mediates ischemic myocardial injury by targeting miR-133a-3p. Theranostics. 2018;8:5855–5869. - PMC - PubMed

LinkOut - more resources